{"title":"[Literature data mining on the current research status of uveitis in China].","authors":"A Lu, K Y Li, G N Su, P Z Yang","doi":"10.3760/cma.j.cn112142-20230929-00121","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To analyze the current research status of uveitis in China. <b>Methods:</b> It was a bibliometric analysis study. Using search formulas covering uveitis and its multiple subtypes, uveitis-related literature in English with publication dates from 2013 to 2022 was retrieved in Web of Science core databases through certain search strategies. This study used the latent Dirichlet allocation (LDA) algorithm to build topic models and analyzed the trends of research topics in recent years. Bibliometric analysis was used to analyze and visualize the bibliometric indicators (e.g., number of publications, citations, and H-index) of the included literature using tools such as VOSviewer software. <b>Results:</b> Over the past decade, China has published 1 657 papers on uveitis, ranking second globally. However, there is still room for improvement in terms of the H-index (58) and citation (12.28 per publication). Countries such as the USA (43.04%) and the United Kingdom (62.54%) were engaged in more international collaboration. We identified ten optimal LDA topics for uveitis literature in China such as immunotherapy, Behçet's disease, and Vogt-Koyanagi-Harada syndrome. Research on uveitis in China was mostly published in <i>Ocular Immunology and Inflammation</i> (92). <b>Conclusions:</b> China has made remarkable progress in uveitis research. Nonetheless, there is still untapped potential to enhance our global academic influence. It is encouraged to promote international collaborations, harness our expertise in areas like Behçet's disease and VKH syndrome, and publish our scientific achievements in high-impact journals.</p>","PeriodicalId":39688,"journal":{"name":"中华眼科杂志","volume":"60 4","pages":"359-369"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华眼科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112142-20230929-00121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To analyze the current research status of uveitis in China. Methods: It was a bibliometric analysis study. Using search formulas covering uveitis and its multiple subtypes, uveitis-related literature in English with publication dates from 2013 to 2022 was retrieved in Web of Science core databases through certain search strategies. This study used the latent Dirichlet allocation (LDA) algorithm to build topic models and analyzed the trends of research topics in recent years. Bibliometric analysis was used to analyze and visualize the bibliometric indicators (e.g., number of publications, citations, and H-index) of the included literature using tools such as VOSviewer software. Results: Over the past decade, China has published 1 657 papers on uveitis, ranking second globally. However, there is still room for improvement in terms of the H-index (58) and citation (12.28 per publication). Countries such as the USA (43.04%) and the United Kingdom (62.54%) were engaged in more international collaboration. We identified ten optimal LDA topics for uveitis literature in China such as immunotherapy, Behçet's disease, and Vogt-Koyanagi-Harada syndrome. Research on uveitis in China was mostly published in Ocular Immunology and Inflammation (92). Conclusions: China has made remarkable progress in uveitis research. Nonetheless, there is still untapped potential to enhance our global academic influence. It is encouraged to promote international collaborations, harness our expertise in areas like Behçet's disease and VKH syndrome, and publish our scientific achievements in high-impact journals.
目的分析中国葡萄膜炎的研究现状。研究方法这是一项文献计量分析研究。通过一定的检索策略,使用涵盖葡萄膜炎及其多种亚型的检索公式,在Web of Science核心数据库中检索到发表日期为2013年至2022年的葡萄膜炎相关英文文献。本研究采用潜狄利克特分配(LDA)算法建立主题模型,并分析了近年来的研究主题趋势。采用文献计量分析法,利用 VOSviewer 软件等工具对收录文献的文献计量指标(如发文数、引文数和 H 指数)进行分析和可视化。研究结果过去十年间,中国共发表葡萄膜炎相关论文 1 657 篇,在全球排名第二。然而,在 H 指数(58)和引用率(12.28/篇)方面仍有提升空间。美国(43.04%)和英国(62.54%)等国家参与了更多的国际合作。我们确定了中国葡萄膜炎文献的十个最佳LDA主题,如免疫疗法、贝赫切特病和Vogt-Koyanagi-Harada综合征。中国关于葡萄膜炎的研究大多发表在《眼免疫学与炎症》(92)上。结论:中国在葡萄膜炎研究方面取得了令人瞩目的进展。尽管如此,中国在提高全球学术影响力方面仍有潜力可挖。我们鼓励促进国际合作,利用我们在贝赫切特病和 VKH 综合征等领域的专业知识,并在高影响力期刊上发表我们的科研成果。